Diagnosis and management of pulmonary embolism in the elderly

European Journal of Internal Medicine

Volumn 25, Issue 4, 2014, Pages 343-349

  Robert Ebadi, Helia ^a   Righini, Marc ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Anticoagulation; Clinical probability; Diagnosis; Elderly; Management; Pulmonary embolism

Indexed keywords

ANTIVITAMIN K; APIXABAN; D DIMER; DABIGATRAN; EDOXABAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN; ANTICOAGULANT AGENT; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING TEST; CLINICAL ASSESSMENT; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; ECHOGRAPHY; ELECTROCARDIOGRAM; FAINTNESS; FIBRINOLYTIC THERAPY; FRAIL ELDERLY; GERIATRIC PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OXYGEN SATURATION; PALPATION; PREDICTIVE VALUE; REVIEW; TACHYCARDIA; TACHYPNEA; THORAX PAIN; THORAX RADIOGRAPHY; AGE; AGED; BLOOD; PULMONARY EMBOLISM; RADIOGRAPHY;

AGE FACTORS; AGED; ANTICOAGULANTS; BIOLOGICAL MARKERS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PULMONARY EMBOLISM;

EID: 84899949011     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.03.009     Document Type: Review

References (98)

1. M.D. Silverstein, J.A. Heit, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study Arch Intern Med 158 1998 585 593
2. F.A. Anderson Jr., H.B. Wheeler, R.J. Goldberg, D.W. Hosmer, N.A. Patwardhan, and B. Jovanovic et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study Arch Intern Med 151 1991 933 938
3. S.Z. Goldhaber, L. Visani, and M. De Rosa Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 353 1999 1386 1389
4. D. Zwierzina, A. Limacher, M. Mean, M. Righini, K. Jaeger, and H.J. Beer et al. Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism J Thromb Haemost 10 2012 2270 2276
5. P.D. Stein, M.L. Terrin, C.A. Hales, H.I. Palevsky, H.A. Saltzman, and B.T. Thompson et al. Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease Chest 100 1991 598 603
6. G. Tisserand, H. Gil, N. Meaux-Ruault, and N. Magy-Bertrand Clinical features of pulmonary embolism in elderly: a comparative study of 64 patients Rev Med Interne 2013 10.1016/j.revmed.2013.07.004
7. S. Timmons, M. Kingston, M. Hussain, H. Kelly, and R. Liston Pulmonary embolism: differences in presentation between older and younger patients Age Ageing 32 2003 601 605
8. N. Kokturk, I.K. Oguzulgen, N. Demir, K. Demirel, and N. Ekim Differences in clinical presentation of pulmonary embolism in older vs younger patients Circ J 69 2005 981 986
9. P.D. Stein, A. Beemath, F. Matta, J.G. Weg, R.D. Yusen, and C.A. Hales et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II Am J Med 120 2007 871 879
10. N. Bajaj, A.L. Bozarth, J. Guillot, J. Kojokittah, S.R. Appalaneni, and C. Cestero et al. Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data J Thromb Thrombolysis 2013 10.1007/s11239-013-0942-8
11. P.L. den Exter, J. van Es, P.M. Erkens, M.J. van Roosmalen, P. van den Hoven, and M.M. Hovens et al. Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism Am J Respir Crit Care Med 187 2013 1369 1373
12. G. Le Gal, and H. Bounameaux Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients J Thromb Haemost 2 2004 1244 1246
13. A. Meguid El Nahas, and A.K. Bello Chronic kidney disease: the global challenge Lancet 365 2005 331 340
14. R. Mehran, E.D. Aymong, E. Nikolsky, Z. Lasic, I. Iakovou, and M. Fahy et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399
15. G. Le Gal, M. Righini, P.M. Roy, G. Meyer, D. Aujesky, and A. Perrier et al. Differential value of risk factors and clinical signs for diagnosing pulmonary embolism according to age J Thromb Haemost 3 2005 2457 2464
16. F.A. Spencer, J.M. Gore, D. Lessard, C. Emery, L. Pacifico, and G. Reed et al. Venous thromboembolism in the elderly. A community-based perspective Thromb Haemost 100 2008 780 788
17. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). The PIOPED Investigators JAMA 263 1990 2753 2759
18. M.A. Rodger, E. Maser, I. Stiell, H.E. Howley, and P.S. Wells The interobserver reliability of pretest probability assessment in patients with suspected pulmonary embolism Thromb Res 116 2005 101 107
19. P.S. Wells, D.R. Anderson, M. Rodger, J.S. Ginsberg, C. Kearon, and M. Gent et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED d-dimer Thromb Haemost 83 2000 416 420
20. A. van Belle, H.R. Buller, M.V. Huisman, P.M. Huisman, K. Kaasjager, and P.W. Kamphuisen et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, d-dimer testing, and computed tomography JAMA 295 2006 172 179
21. D.R. Anderson, M.J. Kovacs, C. Dennie, G. Kovacs, I. Stiell, and J. Dreyer et al. Use of spiral computed tomography contrast angiography and ultrasonography to exclude the diagnosis of pulmonary embolism in the emergency department J Emerg Med 29 2005 399 404
22. J. Wicki, T.V. Perneger, A.F. Junod, H. Bounameaux, and A. Perrier Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score Arch Intern Med 161 2001 92 97
23. G. Le Gal, M. Righini, P.M. Roy, O. Sanchez, D. Aujesky, and A. Perrier et al. Value of d-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism Arch Intern Med 166 2006 176 180
24. F.A. Klok, E. Kruisman, J. Spaan, M. Nijkeuter, M. Righini, and D. Aujesky et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism J Thromb Haemost 6 2008 40 44
25. M. Righini, G. Le Gal, D. Aujesky, P.M. Roy, O. Sanchez, and F. Verschuren et al. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial Lancet 371 2008 1343 1352
26. E. Ceriani, C. Combescure, G. Le Gal, M. Nendaz, T. Perneger, and H. Bounameaux et al. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis J Thromb Haemost 8 2010 957 970
27. M. Righini, G. Le Gal, A. Perrier, and H. Bounameaux Effect of age on the assessment of clinical probability of pulmonary embolism by prediction rules J Thromb Haemost 2 2004 1206 1208
28. A. Perrier, S. Desmarais, M.J. Miron, P. de Moerloose, R. Lepage, and D. Slosman et al. Non-invasive diagnosis of venous thromboembolism in outpatients Lancet 353 1999 190 195
29. M. Di Nisio, A. Squizzato, A.W. Rutjes, H.R. Buller, A.H. Zwinderman, and P.M. Bossuyt Diagnostic accuracy of d-dimer test for exclusion of venous thromboembolism: a systematic review J Thromb Haemost 5 2007 296 304
30. M. Righini, G. Le Gal, A. Perrier, and H. Bounameaux The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies J Am Geriatr Soc 53 2005 1039 1045
31. B. Tardy, B. Tardy-Poncet, A. Viallon, P. Lafond, Y. Page, and C. Venet et al. Evaluation of d-dimer ELISA test in elderly patients with suspected pulmonary embolism Thromb Haemost 79 1998 38 41
32. M. Righini, G. Le Gal, S. De Lucia, P.M. Roy, G. Meyer, and D. Aujesky et al. Clinical usefulness of d-dimer testing in cancer patients with suspected pulmonary embolism Thromb Haemost 95 2006 715 719
33. M. Righini, C. Goehring, H. Bounameaux, and A. Perrier Effects of age on the performance of common diagnostic tests for pulmonary embolism Am J Med 109 2000 357 361
34. M. Righini, P. de Moerloose, G. Reber, A. Perrier, and H. Bounameaux Should the d-dimer cut-off value be increased in elderly patients suspected of pulmonary embolism? Thromb Haemost 85 2001 744
35. R.A. Douma, G. le Gal, M. Sohne, M. Righini, P.W. Kamphuisen, and A. Perrier et al. Potential of an age adjusted d-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts BMJ 340 2010 c1475
36. A. Penaloza, P.M. Roy, J. Kline, F. Verschuren, G. LEG, and S. Quentin-Georget et al. Performance of age-adjusted d-dimer cut-off to rule out pulmonary embolism J Thromb Haemost 10 2012 1291 1296
37. J. van Es, I. Mos, R. Douma, P. Erkens, M. Durian, and T. Nizet et al. The combination of four different clinical decision rules and an age-adjusted d-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded Thromb Haemost 107 2012 167 171
38. H.J. Schouten, H.L. Koek, R. Oudega, G.J. Geersing, K.J. Janssen, and J.J. van Delden et al. Validation of two age dependent d-dimer cut-off values for exclusion of deep vein thrombosis in suspected elderly patients in primary care: retrospective, cross sectional, diagnostic analysis BMJ 344 2012 e2985
39. R.A. Douma, M. Tan, R.E. Schutgens, S.M. Bates, A. Perrier, and C. Legnani et al. Using an age-dependent d-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded Haematologica 97 2012 1507 1513
40. H.J. Schouten, G.J. Geersing, H.L. Koek, N.P. Zuithoff, K.J. Janssen, and R.A. Douma et al. Diagnostic accuracy of conventional or age adjusted d-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis BMJ 346 2013 f2492
41. P.D. Stein, C. Athanasoulis, A. Alavi, R.H. Greenspan, C.A. Hales, and H.A. Saltzman et al. Complications and validity of pulmonary angiography in acute pulmonary embolism Circulation 85 1992 462 468
42. P.S. Wells, J.S. Ginsberg, D.R. Anderson, C. Kearon, M. Gent, and A.G. Turpie et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism Ann Intern Med 129 1998 997 1005
43. I.C. Mos, F.A. Klok, A.D.E.R. Kroft LJ, O.M. Dekkers, and M.V. Huisman Safety of ruling out acute pulmonary embolism by normal computed tomography pulmonary angiography in patients with an indication for computed tomography: systematic review and meta-analysis J Thromb Haemost 7 2009 1491 1498
44. G. Le Gal, M. Righini, O. Sanchez, P.M. Roy, M. Baba-Ahmed, and A. Perrier et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients Thromb Haemost 95 2006 963 966
45. J. Gossner, and R. Nau Geriatric chest imaging: when and how to image the elderly lung, age-related changes, and common pathologies Radiol Res Pract 2013 2013 584793
46. P.S. Wells, D.R. Anderson, and J. Ginsberg Assessment of deep vein thrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests Semin Thromb Hemost 26 2000 643 656
47. M. Righini, H. Bounameaux, and A. Perrier Effect of age on the performance of single detector helical computed tomography in suspected pulmonary embolism Thromb Haemost 91 2004 296 299
48. P.D. Stein, T.L. Chenevert, S.E. Fowler, L.R. Goodman, A. Gottschalk, and C.A. Hales et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III) Ann Intern Med 152 2010 W142 W143
49. M. Righini, M. Nendaz, G. Le Gal, H. Bounameaux, and A. Perrier Influence of age on the cost-effectiveness of diagnostic strategies for suspected pulmonary embolism J Thromb Haemost 5 2007 1869 1877
50. D. Jimenez, R.D. Yusen, R. Otero, F. Uresandi, D. Nauffal, and E. Laserna et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy Chest 132 2007 24 30
51. J. Donze, G. Le Gal, M.J. Fine, P.M. Roy, O. Sanchez, and F. Verschuren et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism Thromb Haemost 100 2008 943 948
52. D. Aujesky, P.M. Roy, F. Verschuren, M. Righini, J. Osterwalder, and M. Egloff et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial Lancet 378 2011 41 48
53. D. Aujesky, D.S. Obrosky, R.A. Stone, T.E. Auble, A. Perrier, and J. Cornuz et al. Derivation and validation of a prognostic model for pulmonary embolism Am J Respir Crit Care Med 172 2005 1041 1046
54. P.D. Stein, and F. Matta Treatment of unstable pulmonary embolism in the elderly and those with comorbid conditions Am J Med 126 2013 304 310
55. P.D. Stein, and F. Matta Vena cava filters in unstable elderly patients with acute pulmonary embolism Am J Med 127 2014 222 225
56. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e419S e494S
57. M. Monreal, and L. Lopez-Jimenez Pulmonary embolism in patients over 90 years of age Curr Opin Pulm Med 16 2010 432 436
58. C. Aymanns, F. Keller, S. Maus, B. Hartmann, and D. Czock Review on pharmacokinetics and pharmacodynamics and the aging kidney Clin J Am Soc Nephrol 5 2010 314 327
59. P.J. Swedko, H.D. Clark, K. Paramsothy, and A. Akbari Serum creatinine is an inadequate screening test for renal failure in elderly patients Arch Intern Med 163 2003 356 360
60. J.B. Schwartz The current state of knowledge on age, sex, and their interactions on clinical pharmacology Clin Pharmacol Ther 82 2007 87 96
61. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
62. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
63. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro III, and H.I. Feldman et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
64. D. Poli, E. Antonucci, M. Zanazzi, E. Grifoni, S. Testa, and W. Ageno et al. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics) Thromb Haemost 107 2012 1100 1106
65. P.K. Maccallum, R. Mathur, S.A. Hull, K. Saja, L. Green, and J.K. Morris et al. Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study BMJ Open 3 2013 e003343
66. W.J. Spruill, W.E. Wade, and H.H. Cobb III Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function Clin Pharmacol Ther 86 2009 468 470
67. L.G. Jacobs Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly Cardiol Clin 26 2008 157 167 [v]
68. A.A. Mangoni, and S.H. Jackson Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications Br J Clin Pharmacol 57 2004 6 14
69. J.W. Eikelboom, and J. Hirsh Combined antiplatelet and anticoagulant therapy: clinical benefits and risks J Thromb Haemost 5 2007 255 263
70. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
71. D.A. Garcia, T.P. Baglin, J.I. Weitz, and M.M. Samama Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e24S e43S
72. A.X. Garg, A. Papaioannou, N. Ferko, G. Campbell, J.A. Clarke, and J.G. Ray Estimating the prevalence of renal insufficiency in seniors requiring long-term care Kidney Int 65 2004 649 653
73. J. Nagge, M. Crowther, and J. Hirsh Is impaired renal function a contraindication to the use of low-molecular-weight heparin? Arch Intern Med 162 2002 2605 2609
74. W. Lim, F. Dentali, J.W. Eikelboom, and M.A. Crowther Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency Ann Intern Med 144 2006 673 684
75. P. Mismetti, S. Laporte-Simitsidis, C. Navarro, P. Sie, P. d'Azemar, and J. Necciari et al. Aging and venous thromboembolism influence the pharmacodynamics of the anti-factor Xa and anti-thrombin activities of a low molecular weight heparin (nadroparin) Thromb Haemost 79 1998 1162 1165
76. M. Nagler, M. Haslauer, and W.A. Wuillemin Fondaparinux - data on efficacy and safety in special situations Thromb Res 129 2012 407 417
77. T.E. Klein, R.B. Altman, N. Eriksson, B.F. Gage, S.E. Kimmel, and M.T. Lee et al. Estimation of the warfarin dose with clinical and pharmacogenetic data N Engl J Med 360 2009 753 764
78. V. Siguret, I. Gouin, M. Debray, C. Perret-Guillaume, J. Boddaert, and I. Mahe et al. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen Am J Med 118 2005 137 142
79. D. Poli, E. Antonucci, S. Testa, A. Tosetto, W. Ageno, and G. Palareti Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation Circulation 124 2011 824 829
80. R.J. Beyth, L.M. Quinn, and C.S. Landefeld Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 1998 91 99
81. N. Ruiz-Gimenez, C. Suarez, R. Gonzalez, J.A. Nieto, J.A. Todoli, and A.L. Samperiz et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry Thromb Haemost 100 2008 26 31
82. C. Kearon, J.S. Ginsberg, M.J. Kovacs, D.R. Anderson, P. Wells, and J.A. Julian et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism N Engl J Med 349 2003 631 639
83. P.M. Kuijer, B.A. Hutten, M.H. Prins, and H.R. Buller Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism Arch Intern Med 159 1999 457 460
84. N. Scherz, M. Mean, A. Limacher, M. Righini, K. Jaeger, and H.J. Beer et al. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism J Thromb Haemost 11 2013 435 443
85. W. Ageno, A.S. Gallus, A. Wittkowsky, M. Crowther, E.M. Hylek, and G. Palareti Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e44S e88S
86. G. Palareti, J. Hirsh, C. Legnani, C. Manotti, A. D'Angelo, and V. Pengo et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study Arch Intern Med 160 2000 470 478
87. N. Kagansky, H. Knobler, E. Rimon, Z. Ozer, and S. Levy Safety of anticoagulation therapy in well-informed older patients Arch Intern Med 164 2004 2044 2050
88. S. Schulman, C. Kearon, A.K. Kakkar, P. Mismetti, S. Schellong, and H. Eriksson et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism N Engl J Med 361 2009 2342 2352
89. R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, and A.S. Gallus et al. Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
90. H.R. Buller, M.H. Prins, A.W. Lensin, H. Decousus, B.F. Jacobson, and E. Minar et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
91. G. Agnelli, H.R. Buller, A. Cohen, M. Curto, A.S. Gallus, and M. Johnson et al. Oral apixaban for the treatment of acute venous thromboembolism N Engl J Med 369 2013 799 808
92. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism N Engl J Med 369 2013 1406 1415
93. M. Franchini, and P.M. Mannucci New anticoagulants for treatment of venous thromboembolism Eur J Intern Med 23 2012 692 695
94. T. Mavrakanas, and H. Bounameaux The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism Pharmacol Ther 130 2011 46 58
95. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
96. S.W. Yates Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient Int J Gen Med 6 2013 167 180
97. M.H. Prins, A.W. Lensing, R. Bauersachs, B. van Bellen, H. Bounameaux, and T.A. Brighton et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies Thromb J 11 2013 21
98. S. Barco, Y.W. Cheung, J.W. Eikelboom, and M. Coppens New oral anticoagulants in elderly patients Best Pract Res Clin Haematol 26 2013 215 224